Rana Lab

Rana Preeclampsia Lab Publications

Saxena K, Haroon S, Rabbani T, Rana S.  Blood flow studies in evaluation of fetal well being:  a study of normal and abnormal pregnancies.  J Obstet Gynecol lndia 2001; 51:64-72.

Kumar RM, Uduman S, Rana S, Kochiyil JK, Usmani A, Thomas L.  Sera-prevalence and mother-to infant transmission of Hepatitis E virus among pregnant women in the United Arab Emirates.  Euro J Obstet Gynecol Reprod Biology 2001; 100: 9-15. PMID: 11728649.

Abramowicz JS, Rana S, Abramowicz S. Fetal cheek-to-cheek diameter in the prediction of mode of delivery.  Am J Obstet Gynecol 2005; 192 (4): 1205-13. PMID: 15846203.

Rana S, Lindheimer M, Hibbard J, Pliskin N. Neuropsychological performance in normal pregnancy and preeclampsia. Am J Obstet Gynecol 2006; 195 (1): 186-91. PMID: 16579917.

Cohen A, Lim KH, Lee Y, Rana S, Karumanchi SA, Brown F.  Circulating levels of antiangiogenic marker soluble FMS-like tyrosine kinase1 are elevated in women with pregestational diabetes and preeclampsia:  angiogenic markers in preeclampsia and preexisting diabetes.  Diabetes Care 2007; 30(2): 375-7. PMID: 17259514.

Rana S, Karumanchi SA, Levine RJ, Venkatesha S, Rauh-Hain JA, Tamez H, Thadhani R.  Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia.  Hypertension 2007; 50 (1): 137-42. PMID: 17515455.

Signore C, Mills JL, Qian C, Yu KF, Rana S, Karumanchi SA, Levine RJ.  Circulating soluble endoglin and placental abruption.  Prenat Diagn. 2008; 28(9): 852-8. PMID: 18702104.

**Rauh-Hain A, Rana S, Tamez H, Wang A, Cohen B, Cohen A, Brown F,  Ecker JL, Karumanchi SA, Thadhani R: Risk for developing gestational diabetes in women with twin pregnancies. J Matern Fetal Neonatal Med. 2009; 25:1-7. PMID: 19340713.

**Young B, Levine RJ, Salahuddin S, Qian C, Lim KH, Karumanchi SA, Rana S: The use of angiogenic biomarkers to differentiate non-HELLP related thrombocytopenia from HELLP syndrome. J Matern Fetal Neonatal Med. 2010; 23(5): 366-70. PMID: 19701867.

**Steinberg G, Lee C, Rauh-Hain JA, Ecker J, Khankin EV, Hsu CD, Cohen B, Rana S, Karumanchi SA, Thadhani R, Hacker MR, Lim KH. Early-pregnancy soluble Fas levels in idiopathic small-for-gestational-age pregnancies. Am J Obstet Gynecol. 2010; 202(3): 299. e1-7. PMID: 20207247.

Powe CE, Seely EW, Rana S, Bhan I, Ecker J, Karumanchi SA, Thadhani R. First trimester vitamin D, vitamin D binding protein, and subsequent preeclampsia. Hypertension. 2010; 56(4): 758-63. PMID: 20733087.

Mijal RS, Holzman CB, Rana S, Karumanchi SA, Wang J, Sikorskii A. Mid-pregnancy levels of angiogenic markers in relation to maternal characteristics. Am J Obstet Gynecol. 2011; 204(3): 244.e1-12. PMID: 21145529.

Powe CE, Ecker J, Rana S, Wang A, Ankers L, Ye J, Levine RJ, Karumanchi SA, Thadhani R. Preeclampsia and the risk of large for gestational age infants. Am J Obstet Gynecol. 2011; 204(5): 425.e1-6. PMID: 21371687.

**Silasi M, Rana S, **Powe CE, Cohen B, Lim KH, Karumanchi SA, Stillman I. Trisomy 13 and placental angiogenic proteins. Am J Obstet Gynecol. 2011; 204(6): 546.e1-4. PMID: 21507376.

Poston L, Igosheva N, Mistry HD, Seed PT, Shennan AH, Rana S, Karumanchi SA, Chappell LC. The role of oxidative stress and antioxidant supplementation in pregnancy disorders. Am J Clin Nutr. 2011; 94(6): 1980S-5S. PMID: 21613560.

Mijal RS, Holzman CB, Rana S, Karumanchi A, Wang J, Sikorskii A. Midpregnancy levels of angiogenic factors and pathways to preterm delivery. J Matern Fetal Neonatal Med. 2012; 25(7): 1135-41. PMID: 21939291.

**Vadnais, M, Rana S, Quant H, Salahuddin S, Dodge L, Lim KH, Karumanchi SA, Hacker M. The impact of magnesium sulfate therapy on angiogenic factors in preeclampsia. Pregnancy Hypertens. 2012; 2(1): 16-21. PMID: 22247820.

**Young B, Hacker M, Rana S. Physician’s knowledge of future vascular disease in women with preeclampsia. Hypertens Pregnancy. 2012; 31(1): 50-8. PMID: 21332326.

Rajakumar A, **Cerdeira AS, Rana S, Zsengeller A, Edmunds L, Jeyabalan A, Hubel CA, Stilmann IE, Parikh SM, Karumanchi SA. Transcriptionally active syncytial aggregates in the maternal circulation may contribute to circulating sFlt1 in preeclampsia. Hypertension. 2012; 59(2): 256-64. PMID: 22215706.

Rana S, **Powe CE, Salahuddin S, Verlohren S, Perschel FH, Levine RJ, Lim KH, Wenger JB, Thadhani R, Karumanchi SA. Angiogenic Factors and the Risk of Adverse Outcomes in Women with Suspected Preeclampsia. Circulation. 2012; 125(7): 911-9. PMID: 22261192.

**Schnettler WT, Hacker MR, Barber R, Rana S. Management of abnormal serum markers in the absence of aneuploidy or neural tube defects. J Matern Fetal Neonatal Med. 2012; 25(10): 1895-8. PMID: 22372385.

**Khankin EV, Hacker MR, Zelop CM, Karumanchi SA, Rana S. Intravital high frequency ultrasonography of cardiovascular and uteroplacental blood flow in mouse pregnancy. Pregnancy Hypertens. 2012; 2(2): 84-92. PMID: 22544045.

Patten IS#, Rana S#, Shahul S, Rowe GC, Jang C, Liu L, Hacker MR, **Rhee JS, Mitchell J, Mahmood F, Hess P, Farrell C, Koulisis N, Khankin EV, Burke SD, Tudorache I, Bauersachs J, Monte F, Hilfiker-Kleiner D, Karumanchi SA, Arany Z. Cardiac Angiogenic Imbalance Leads to Peri-partum Cardiomyopathy. Nature. 2012. 2012; 485: 333–338.  #equal contribution. PMID: 22596155.

Rana S, Hacker MR, Merport Modest A, Salahuddin S, Lim KH, Verlohren S, Perschel FH, Karumanchi SA. Circulating Angiogenic Factors and Risk of Adverse Maternal and Perinatal Outcomes in Twin Pregnancies with Suspected Preeclampsia. Hypertension. 2012; 60(2): 451-8. PMID: 22753210.

Shahul S, **Rhee J, Hacker MR, Gulati G, Mitchell JD, Hess P, Mahmood F, Arany Z, Rana S, Talmor D. Subclinical Left Ventricular Dysfunction in Preeclamptic Women with Preserved Left Ventricular Ejection Fraction: A 2D Speckle Tracking Imaging Study. Circ Cardiovasc Imaging. 2012; 5(6): 734-9. PMID: 22891044.

Rana S, **Cerdeira AS, Wenger J, Salahuddin S, Lim KH, Ralston RJ, Thadhani R, Karumanchi SA. Plasma concentrations of soluble endoglin versus standard evaluation in patients with suspected preeclampsia. PLoS One. 2012; 7(10): e48259. PMID: 23110221.

**Lely TA, Salahuddin S, Holwerda KM, Karumanchi SA, Rana S. Circulating Lymphangiogenic Factors in Preeclampsia. Hypertens Pregnancy. 2013; 32(1): 42-9. PMID: 22957504. 

Schaarschmidt W, Rana S, Stepan H. The course of angiogenic factors in early- versus late-onset preeclampsia and HELLP syndrome. J Perinat Med. 2013; 41(5): 5111-6. PMID: 23612628.

**Schnettler WT, Dukhovny D, Wenger J, Salahuddin S, Ralston SJ, Rana S. Cost and resource implications with serum angiogenic factor estimation in the triage of preeclampsia. BJOG. 2013; 120(10): 1224-32. PMID: 23647884.

Rana S, **Schnettler WT, **Powe C, Wenger J, Salahuddin S, **Cerdeira AS, Verlohren S, Perschel FH, Arany Z, Lim KH, Thadhani R, Karumanchi SA. Clinical Characterization and Outcomes of Preeclampsia with Normal Angiogenic Profile. Hypertens Pregnancy. 2013; 32(2): 189-201. PMID: 23725084.

Rana S, Karumanchi S.A, Lindheimer MD. Angiogenic Factors in Diagnosis, Management, and Research in Preeclampsia. Hypertension. 2014; 63(2): 198-202. PMID: 24166749.

Bdolah Y, Elchalal U, Natanson-Yaron S, Yechiam H, Bdolah-Abram T, Greenfield C, Goldman-Wohl D, Milwidsky A, Rana S, Karumanchi SA, Yagel S, Hochner-Celnikier D. Relationship between nulliparity and preeclampsia may be explained by altered circulating soluble fms-like tyrosine kinase 1. Hypertens Pregnancy. 2014; 33(2): 250-9. PMID: 24304210.

Cohen AL, Wenger JB, James-Todd T, Lamparello BM, Halprin E, Serdy S, Fan S, Horowitz GL, Lim KH, Rana S, Takoudes TC, Wyckoff JA, Thadhani R, Karumanchi SA, Brown FM. The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes. Hypertens Pregnancy. 2014; 33(1): 81-92. PMID: 24354578.

Rana S, Rajakumar A, **Geahchan C, Salahuddin S, **Cerdeira AS, Burke S, George E, Granger J, Karumanchi SA. Ouabain Downregulates sFlt1 Production by Inhibiting HSP27-Dependent HIF-1a Protein Expression. FASEB J. 2014; 28(10): 4324-34. PMID: 24970393.

**Baltiajan K, Hecht J, Wenger J, Salahuddin S, Zsengeller Z, Thadhani R, Karumanchi SA, Rana S. Placental lesions of vascular insufficiency are associated with anti-angiogenic state in women with preeclampsia. Hypertens Pregnancy. 2014;33(4):427-39. PMID: 25062083.

**March MI, Gupta M, Perport Modest A, Wu L, Hacker MR, Martin C, Rana S. Maternal Risk Factors for Neonatal Necrotizing Enterocolitis.  J Matern Fetal Neonatal Med. 2014; 27:1-6. PMID: 25162307.

**Raghuraman N, **March MI, Hacker MR, Merport Modest A, Wenger J, Narcisse R, Louis J, Scott J, Rana S. Adverse Maternal and Fetal Outcomes and Deaths related to Preeclampsia and Eclampsia in Haiti. Pregnancy Hypertens, 2014; 4(4):279–286. PMID: 26104817.

Palomaki GE, Haddow JE, Haddow H, Salahuddin S, Geahchan C, **Cerdeira AS, Verlohren S, Perschel FH, Horowitz G, Thadhani R, Karumanchi SA, Rana S. Modeling Risk for Angiogenesis-Related Maternal Syndrome Requiring Early Delivery in a Cohort of Women Referred for Preeclampsia Evaluation. Prenat Diagn. 2015; 35(4): 386-93. PMID: 25641027.

**March MI, **Geahchan C, Wenger J, **Raghuraman N, Berg A, Haddow H, Mckeon BA, Narcisse R, David JL, Scott J, Thadhani R, Karumanchi SA, Rana S. Circulating Angiogenic Factors and the Risk of Adverse Outcomes among Haitian Women with Preeclampsia. PLoS One. 2015 May 12; 10(5): e0126815. PMID: 25965397.

**Goel A, Maski MR, Bajracharya S, Wenger JB, Zhang D, Salahuddin S, Shahul S, Thadhani R, Seely EW, Karumanchi SA, Rana S. Epidemiology and Mechanisms of De Novo Hypertension in the Postpartum Period. 2015. Circulation. 2015 Nov 3; 132 (18): 1726-33. PMID: 26416810.

Shahul S, Mahmood E, Minhaj MM, Robb D. Kociol RD, Nizamuddin J, Wenger JB, Mueller A, Shaefi S, Scavone B, Tung A, Talmor D, Rana S. Racial Disparities in Maternal and Fetal Outcomes in Women with Preeclampsia/Eclampsia. Hypertens Pregnancy. 2015; 34(4):506-15. PMID: 26636247.

Kim MY, Buyon JP, Guerra MM, Rana S, Laskin CA, Petri M, Lockshin MD, Sammaritano L, Branch WD, Porter FT, Merrill JT, Stephenson MD, Gao Q, Karumanchi SA, and Salmon JE. Angiogenic Factor Imbalance Early in Pregnancy Predicts Adverse Outcomes in Patients with Lupus and Antiphospholipid Antibodies: Results of the PROMISSE Study. Am J Obstet Gynecol. 2016; 214(1): 108.e1-108.e14. PMID: 26432463.

**Baltajian K, **Bajracharya S, Wenger JB, Berg A, Geahchan C, Salahuddin S, Thadhani R, Karumanchi SA, Rana S. Sequential angiogenic factor estimation to predict adverse pregnancy outcomes among patients admitted for evaluation of preeclampsia. Am J Obstet Gynecol. 2016 Jul; 215(1):89. e1-89. e10. PMID: 26827880.

Damp J, Givertz MM, Semigran M, Alharethi R, Ewald G, Felker GM, Bozkurt B, Boehmer J, Haythe J, Skopicki H, Hanley-Yanez K, Pisarcik J, Halder I, Gorcsan J 3rd, Rana S, Arany Z, Fett JD, McNamara DM; IPAC Investigators. Relaxin-2 and Soluble Flt1 Levels in Peripartum Cardiomyopathy: Results of the Multicenter IPAC Study. JACC Heart Fail. 2016 May; 4(5):380-8. PMID: 26970832.

Salahuddin S, Wenger JB, Zhang D, Thadhani R, Karumanchi SA, Rana S. KRYPTOR-automated angiogenic factor assays and risk of preeclampsia-related adverse outcomes. Hypertens Pregnancy. 2016;35(3): 330-45. PMID: 27028795.

Shahul S, Medvedofsky D, Wenger JB, Nizamuddin J, Brown SM, Bajracharya S, Salahuddin S, Thadhani R, Mueller A, Tung A, Lang RM, Arany Z, Talmor D, Karumanchi SA, Rana S. Circulating Antiangiogenic Factors and Myocardial Dysfunction in Hypertensive Disorders of Pregnancy. Hypertension. 2016 Jun; 67(6): 1273-80. PMID: 27113052.

Zsengellér ZK, Rajakumar A, Hunter JT, Salahuddin S, Rana S, Stillman IE, Ananth Karumanchi S. Trophoblast mitochondrial function is impaired in preeclampsia and correlates negatively with the expression of soluble fms-like tyrosine kinase 1. Pregnancy Hypertens. 2016; 6 (4):313-319. PMID: 27939475.

Nadkarni NA, Rajakumar A, Mokhashi N, Burke SD, Rana S, Salahuddin S, Dang Q, Thadhani R, Krishnan R, Stossel TP, Karumanchi SA. Gelsolin is an endogenous inhibitor of syncytiotrophoblast extracellular vesicle shedding in pregnancy. Pregnancy Hypertens. 2016; 6 (4):333-339. PMID: 27939478.

Banayan J, Rana S, Mueller A, Tung A, Ramadan H, Arany Z, Nizamuddin J, Novack V, Scavone B, Brown SM, Shahul S. Cardiogenic shock in pregnancy: Analysis from the National Inpatient Sample. Hypertens Pregnancy. 2016 Nov 11:1-7. PMID: 27835031.

Siddiqui M, Minhaj M, Mueller A, Tung A, Scavone B, Rana S, Shahul S. Increased Perinatal Morbidity and Mortality Among Asian American and Pacific Islander Women in the United States. Anesth Analg. 2017 Mar;124(3):879-886. PMID: 28099290.

**Ramadan H, Rana S, Mueller A, Medvedofsky D, Nizamuddin J, Bajracharya S, Salahuddin S, Thadhani R, Tung A, Arany Z, Karumanchi SA, Shahul S. Myocardial performance index in hypertensive disorders of pregnancy: The relationship between blood pressures and angiogenic factors. 2017. Hypertens Pregnancy. PMID: 28609171.

Dutta A, Brito K, Khramstova G, Mueller A, Chinthala S, Alexander D, Adu D, Ibigbami T, Olamijulo J, Odetunde A, Adigun K, Pruitt L, Olopade O, Ojengbede O, Rana S, Olopade CO. Household air pollution and angiogenic factors in pregnant Nigerian women: A randomized controlled ethanol cookstove intervention. 2017. Science of the Total Environment 599–600 (2017) 2175–2181. PMID: 28575932.

Chhabra N, Gupta A, Chibber R, Minhaj M, Hofer J, Mueller A, Tung A, O’Connor MF, Scavone B, Rana S, Shahul SS. Outcomes and mortality in parturient and non-parturient patients with peripartum cardiomyopathy: a national readmission database study. Pregnancy Hypertens. 2017 Oct; 10 :143-148. PMID: 29153668.

**Kang E, **Sugarman R, **Ramadan H, Mueller A, Shahul S, **Perdigao JL, Louis DJ, Narcisse R, Sannon H, Magee L, Rana S. Prevalence of postpartum hypertension in rural Haiti. Pregnancy Hypertens. 2017 Oct; 10 :135-142. PMID: 29153666.

Shahul S, Ramadan H, Mueller A, Nizammudin J, Nasim R, Perdigao JL, Chinthala S, Tung A, Rana S. Abnormal mid-trimester cardiac strain in women with chronic hypertension predates superimposed preeclampsia. Pregnancy Hypertens. 2017 Oct ; 10:251-25.

Dutta A, Khramstova G, Brito K, Alexander D, Mueller A, Chinthala S, Adu D, Ibigbami T, Olamijulo J, Odetunde A, Adigun K, Pruitt L, Hurley I, Olopade O, Ojengbede O, Rana S, Olopade CO. Household Air Pollution and Chronic Hypoxia in the Placenta of Pregnant Nigerian Women: A Randomized Controlled Ethanol Cookstove Intervention. Sci Total Environ. 2018 Apr 1;619-620:212-220. PMID: 29149745.

Chan SL, Rana S, Chinthala S, Salahuddin S, Yeo KT. Analytical validation of soluble fms-like tyrosine and placental growth factor assays on BRAHMS KRYPTOR Compact Plus automated immunoassay platform. Pregnancy Hypertens. 2018 Jan; 11:66-70. PMID: 29523276.

Shahul S, Ramadan H, Nizamuddin J, Mueller A, Patel V, Dreixler J, Tung A, Lang RM, Weinert L, Nasim R, Chinthala S, Rana S. Activin A and Late Postpartum Cardiac Dysfunction Among Women With Hypertensive Disorders of Pregnancy. Hypertension. 2018 Jul;72(1):188-193. PMID: 29844146.

Rana S, Salahuddin S, Mueller A, Berg AH, Thadhani RI, Karumanchi SA. Angiogenic Angiogenic Biomarkers in Triage and Risk for Preeclampsia with Severe Features. Pregnancy Hypertens. 2018 Jul ; 13:100-106. PMID: 30177034.

Minhas R, Young D, Naseem R, Mueller A, Chinthala S, Perdigao JP, Yeo KT, Chan SL, Tung A, Bregand White J, Shahul S, Rana S. Association of levels of blood pressure control during pregnancy and angiogenic profile at delivery among women with chronic hypertension. Pregnancy Hypertens. 2018 Oct; 14: 110-114. PMID: 30527096.

Nizamuddin J, Gupta A, Patel V, Minhaj M, Nizamuddin SL, Mueller AL, Naseem H, Tung A, Rana S, Shahul S. Hypertensive Diseases of Pregnancy Increase Risk of Readmission With Heart Failure: A National Readmissions Database Study. Mayo Clin Proc. 2018 Dec 18. PMID: 30577972.

Perdigao JL, Chintala S, Mueller A, Chan SL, Ramadan H, Nasim R, Young D, Minhas R, Shahul S, Rana S. Angiogenic factors and adverse maternal outcomes among admitted patients with hypertensive disorders of pregnancy. Hypertension. 2019 Apr;73(4):868-877. PMID: 30798660. PMID: 30798660. Selected as high Impact paper in HTN- summer 2019.

Wang V, Mueller A, Minhas R, Yan J, Guo J, Rana S. Understanding and Comparing Practices of Managing Patients with Hypertensive Disorders of Pregnancy in Urban China and the United States. Pregnancy Hypertens. 2019.

 

Clinical Trials:

Magee LA, von Dadelszen P, Rey E, Ross S, Asztalos E, Murphy KE, Menzies J, Sanchez J, Singer J, Gafni A, Gruslin A, Helewa M, Hutton E, Lee SK, Lee T, Logan AG, Ganzevoort W, Welch R, Thornton JG, Moutquin JM. Less-tight versus tight control of hypertension in pregnancy. N Engl J Med. 2015; 372(24):2367-8. Site PI for CHIPS group. PMID: 26061848.

Magee LA, for the CHIPS Study Group, Dadelszen PV, Singer, Lee T, Rey E, Ross S, Asztalos E, Murphy KE, Menzies J, Sanchez J, Gafni IA, Gruslin A, Helewa M, Hutton E, Koren G, SK Lee SK, AG Logan AG, Ganzevoort JW, Welch R, Thornton JG, Moutquins J-M. Do labetalol and methyldopa have different effects on pregnancy outcome? Analysis of data from the Control of Hypertension In Pregnancy Study (CHIPS) trial. BJOG.2016;123(7):1143-51. Site PI for CHIPS group. PMID: 26265372.

Magee LA; CHIPS Study Group, von Dadelszen P, Singer J, Lee T, Rey E, Ross S, Asztalos E, Murphy KE, Menzies J, Sanchez J, Gafni A, Gruslin A, Helewa M, Hutton E, Koren G, Lee SK, Logan AG, Ganzevoort JW, Welch R, Thornton JG, Moutquin JM. Control of Hypertension In Pregnancy Study randomised controlled trial-are the results dependent on the choice of labetalol or methyldopa? BJOG. 2016; 123(7):1135-41. Site PI for CHIPS group. PMID: 26259808.

Pels A, Mol BWJ, Singer J, Lee T, von Dadelszen P, Ganzevoort W, Asztalos E, Magee LA; CHIPS Study Group. Influence of Gestational Age at Initiation of Antihypertensive Therapy: Secondary Analysis of CHIPS Trial Data (Control of Hypertension in Pregnancy Study). Hypertension. 2018 Jun;71(6):1170-1177.

Hakim S, Bano I, Bhardwaj NA, Anis A, Rana S. Dermoid cyst of mons pubis: a case report. J Obstet Gynecol India 2000; 51: 121.

Rana S, Stanhope RC, Gaffey T, Morrey BF, Dumesic DA.  Retroperitoneal endometriosis causing unilateral hip pain.  Obstet Gynecol 2001; 98:970-2. PMID: 11704226.

Rana S, Warren BK, Yamada SD.  Stage IIIC small cell carcinoma of the ovary:  survival with conservative surgery and chemotherapy.  Obstet Gynecol 2004; 103(5 Pt2): 1120-3. PMID: 15121630.

Rana S, Venkatesha S, DePaepe M, Chien E, Paglia M, Karumanchi SA.  Cytomegalovirus-induced mirror syndrome associated with elevated levels of circulating antiangiogenic factors.  Obstet Gynecol 2007; 109(2Pt2): 549-52. PMID: 17267891.

Shan HY, Rana S, Epstein FH, Stillman IE, Karumanchi SA, Williams ME.  Use of circulating antiangiogenic factors to differentiate other hypertensive disorders from preeclampsia in a pregnant woman on dialysis.  Am J Kidney Dis. 2008; 51(6): 1029-32. PMID: 18455853.

**Young B, Takoudes T, Lim KH, Rana S: Rupture of the posterior cul-de-sac during spontaneous labor. Obstet Gynecol. 2010; 115: 414-7. PMID: 20093863.

**Rhee J, **Young BC, Rana S. Angiogenic Factors and Renal Disease in Pregnancy. Case reports in Obstetrics and Gynecology. 2011. PMID: 22567501.

**Bixel K, Silasi M, Zelop CM, Lim KH, Zsengeller Z, Stillman I, Rana S. Placental Origins of Angiogenic Dysfunction in Mirror Syndrome. Hypertens Pregnancy. 2012; 31(2): 211-7. PMID: 22150085.

**Quant H, Arden D, Takoudes T, Rana S. Angiogenic factors and pregnant woman with new-onset seizures. Hypertens Pregnancy. Hypertens Pregnancy. 2012; 31(2): 207-10. PMID: 22380455.

Rana S.  Practical strategies in Obstetrics & Gynecology (book review).  Fertility Sterility 2000,74 (2): 425.

Rana S, Lindheimer MD, Karumanchi SA.  Angiogenic proteins as markers for predicting preeclampsia.  Expert Review of Obstet Gynecol 2007; 2(1): 61-65.

Wang A, Rana S, Karumanchi SA: Preeclampsia. Physiology. 2009; 24:147-58.

Tjoa M, Khankin E, Rana S, Karumanchi SA. Book Chapter: Angiogenic and anti-angiogenic factors. Placental Bed Disorders: Basic Science & its translation to obstetrics, Cambridge University Press. 2010, Section 7, Chapter 21.

Maski M, Rana S, Karumanchi SA. Book Chapter: Biomarkers in Obstetric Medicine. Biomarkers in Medicine, Drug Discovery, and Environmental Health, John Wiley and Sons. 2010, Section II, Chapter 13.

**Silasi M, Cohen B, Karumanchi SA, Rana, S: Abnormal Placentation, Angiogenic Factors, and the Pathogenesis of Preeclampsia. Obstetrics and Gynecology Clinics of North America. 2010; 37(2): 239-253.

Rana S, Karumanchi SA, Norwitz E. Book Chapter: Screening for hypertensive disorders of pregnancy. Hypertension in Pregnancy, Cambridge University Press. 2010, Chapter 4.

**Goel A and Rana S. Angiogenic Factors in Preeclampsia: Potential for Diagnosis and Treatment. Curr Opin Nephrol Hypertens. 2013; 22(6): 643-650.

Karumanchi SA, Rana S, Robert Taylor. Book Chapter: Angiogenesis and Preeclampsia. Chesley’s hypertensive disorders in pregnancy, Fourth Edition. Elsevier Inc. 2014, Chapter 6.

Rana S, Karumanchi SA. Book Chapter: Pathophysiology of preeclampsia. Fetal and Neonatal Physiology, Fifth Edition. Elsevier Inc, 2015, Chapter 172.

Rana S, Karumanchi SA. Book Chapter: Angiogenic factors in Pre-eclampsia. World Clinics Obstetrics and Gynecology- Preeclampsia. 2016; 5(1): pp1-143.

Rana S, Sannon H. Angiogenic proteins: Can these biomarkers help to prevent maternal deaths related to preeclampsia? Editorial. Hypertension. 2017 Mar; 69(3):401-403.

Rana S. Does vasoactive peptide ELABELA reveal essential mechanisms for preeclampsia development?”. OB-GYN management. October 29, 2017.

Rana S, Lemoine E, Granger JP, Karumanchi SA. Preeclampsia: Pathophysiology, Challenges, and Perspectives. Review. Circ Res. 2019 Mar 29;124(7):1094-1112. PMID: 30920918.

Ahn Roy, Gonzalez G, Nadel T, TenBroeck S, Rana S. Literature Review Report: Promising Global Practices to Improve Maternal Mortality Outcomes in the United States. NORC at the University of Chicago. Report to the US Health Resources and Services Administration, Department of Health and Human Services. (2018). December 3, 2018. pp. 1-56.

 

https://www.uchicagomedicine.org/womens-health-articles/global-health-research-in-haiti-improves-prenatal-care-back-home

https://www.uchicagomedicine.org/womens-health-articles/what-you-need-to-know-about-preeclampsia

IIRRH to Hold Conference on Reproductive Health from Nov 4 Webindia123. November 01, 2016.

How Do Women Go from Having a Pregnancy Complication to Developing Cardiovascular Disease? JAMA. October 17, 2018.

Pregnancy HTN Disorders Tied to Cardiomyopathy Risk. MedPage Today.March 08, 2016.

https://wgntv.com/2019/02/18/preeclampsia-in-pregnancy/ WGN TV’s Living Healthy Chicago, Feb 18th, 2019

News conference MOMMA act- Senator Dick Durbin, March 18th, 2019

Recognized as an Expertscape World Expert in Pre-Eclampsia. May 22, 2019. http://www.expertscape.com/ex/pre-eclampsia

Facebook live “ Understanding preeclampsia.” May 22, 2019. https://www.facebook.com/UChicagoMed/posts/2210025809074904

Chicago Suntimes-May 22, 2019-What pregnant women need to know about preeclampsia